1. Home
  2. COCP vs GTIM Comparison

COCP vs GTIM Comparison

Compare COCP & GTIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • GTIM
  • Stock Information
  • Founded
  • COCP 2006
  • GTIM 1987
  • Country
  • COCP United States
  • GTIM United States
  • Employees
  • COCP N/A
  • GTIM N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • GTIM Restaurants
  • Sector
  • COCP Health Care
  • GTIM Consumer Discretionary
  • Exchange
  • COCP Nasdaq
  • GTIM Nasdaq
  • Market Cap
  • COCP 15.7M
  • GTIM 17.1M
  • IPO Year
  • COCP N/A
  • GTIM 1990
  • Fundamental
  • Price
  • COCP $1.80
  • GTIM $1.64
  • Analyst Decision
  • COCP Strong Buy
  • GTIM
  • Analyst Count
  • COCP 1
  • GTIM 0
  • Target Price
  • COCP $6.00
  • GTIM N/A
  • AVG Volume (30 Days)
  • COCP 21.6K
  • GTIM 11.2K
  • Earning Date
  • COCP 08-13-2025
  • GTIM 07-31-2025
  • Dividend Yield
  • COCP N/A
  • GTIM N/A
  • EPS Growth
  • COCP N/A
  • GTIM 65.30
  • EPS
  • COCP N/A
  • GTIM 0.09
  • Revenue
  • COCP N/A
  • GTIM $144,322,000.00
  • Revenue This Year
  • COCP N/A
  • GTIM N/A
  • Revenue Next Year
  • COCP N/A
  • GTIM N/A
  • P/E Ratio
  • COCP N/A
  • GTIM $17.60
  • Revenue Growth
  • COCP N/A
  • GTIM 4.14
  • 52 Week Low
  • COCP $1.12
  • GTIM $1.51
  • 52 Week High
  • COCP $3.26
  • GTIM $3.45
  • Technical
  • Relative Strength Index (RSI)
  • COCP 69.71
  • GTIM 43.17
  • Support Level
  • COCP $1.46
  • GTIM $1.61
  • Resistance Level
  • COCP $1.60
  • GTIM $1.82
  • Average True Range (ATR)
  • COCP 0.08
  • GTIM 0.10
  • MACD
  • COCP 0.02
  • GTIM -0.01
  • Stochastic Oscillator
  • COCP 92.31
  • GTIM 19.74

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About GTIM Good Times Restaurants Inc.

Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; frozen custard; slides and drinks.

Share on Social Networks: